Motus GI Holdings Operating Cycle 2011-2026 | MOTS

Annual Operating Cycle Motus GI Holdings

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.45 K	1.43 K	1.38 K	723	3 K	206	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.45 K	206	1.7 K

Quarterly Operating Cycle Motus GI Holdings

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.82 K	-	3.44 K	2.45 K	9.2 K	-	1.17 K	1.19 K	3.93 K	-	939	1.67 K	2.66 K	-	2.39 K	10.5 K	2.93 K	-	3.47 K	47.7 K	50.5 K	-	49.5	68.7	126	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
50.5 K	49.5	7.8 K

Operating Cycle of other stocks in the Diagnostics research industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	170	-	-6.23 %	$ 30.6 M	Germany
ICON Public Limited Company ICLR	68.5	$ 98.33	0.9 %	$ 8.11 B	Irlanda
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	73.8	-	-6.19 %	$ 10.5 M	USA
Charles River Laboratories International CRL	65	$ 155.46	1.83 %	$ 7.71 B	USA
Bioventus BVS	259	$ 8.62	0.23 %	$ 574 M	USA
DexCom DXCM	202	$ 64.24	-1.56 %	$ 25.1 B	USA
Castle Biosciences CSTL	97.9	$ 25.56	0.95 %	$ 710 M	USA
CareDx, Inc CDNA	51.5	$ 17.01	3.4 %	$ 906 M	USA
Accelerate Diagnostics AXDX	489	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	91.7	$ 103.57	0.29 %	$ 19.5 B	USA
Guardant Health GH	128	$ 85.49	1.75 %	$ 10.7 B	USA
Global Cord Blood Corporation CO	202	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.8 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	185	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	77.4	$ 14.77	0.61 %	$ 447 M	USA
PRA Health Sciences, Inc. PRAH	1.22 K	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 17.88	-6.63 %	$ 2.32 B	USA
Anixa Biosciences ANIX	275	$ 2.83	-1.05 %	$ 91.8 K	USA
Danaher Corporation DHR	143	$ 187.32	0.57 %	$ 134 B	USA
IQVIA Holdings IQV	73.9	$ 164.72	1.1 %	$ 28.3 B	USA
Biocept BIOC	134	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	177	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	216	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	198	$ 118.94	2.92 %	$ 18.9 B	USA
Quest Diagnostics Incorporated DGX	54.2	$ 199.7	-0.46 %	$ 22.2 B	USA
QIAGEN N.V. QGEN	172	-	-	$ 10.6 B	Niderland
Agilent Technologies A	161	$ 111.51	-0.06 %	$ 33.9 B	USA
BioNano Genomics BNGO	329	$ 1.11	-0.89 %	$ 1.41 M	USA
DarioHealth Corp. DRIO	251	$ 9.0	-0.99 %	$ 255 M	Israel
Neogen Corporation NEOG	213	$ 9.09	-2.78 %	$ 1.97 B	USA
National Research Corporation NRC	29.4	$ 16.52	0.12 %	$ 370 M	USA
Chembio Diagnostics CEMI	164	-	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	244	$ 1.33	4.72 %	$ 399 M	USA
Co-Diagnostics CODX	405	-	-	$ 79.8 M	USA
Medpace Holdings MEDP	50.4	$ 450.41	1.48 %	$ 13 B	USA
DermTech DMTK	114	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.4	$ 1 173.74	0.49 %	$ 24.2 B	Schweiz
Personalis PSNL	55.8	$ 6.72	1.97 %	$ 398 M	USA
NeoGenomics NEO	102	$ 7.88	-1.25 %	$ 1.01 B	USA
Enzo Biochem ENZ	206	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 187.85	-1.29 %	$ 18.5 B	USA
Sotera Health Company SHC	80.3	$ 13.42	0.71 %	$ 3.81 B	USA
Invitae Corporation NVTA	368	-	-	$ 21.2 M	USA
OPKO Health OPK	285	$ 1.19	2.59 %	$ 826 M	USA